Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04414397 · ClinicalTrials.gov registry record · Phase 3
A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 205
- Enrollment target
NCT04414397 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 205 participants.
The verdict
NCT04414397, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 205 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing
Interventions
- DEVICE JUVÉDERM® VOLUMA® XC
- OTHER No-treatment control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2020-05-28 |
| Est. Completion | 2022-10-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04414397
The ClinicalTrials.gov registry entry for NCT04414397 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which JUVÉDERM® VOLUMA® XC is the first listed.
NCT04414397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04414397 about?
NCT04414397 is a clinical study titled "A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old". The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing
What is the current status of trial NCT04414397?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 205 participants. The study started on 2020-05-28. Estimated completion is 2022-10-17.
What interventions are being tested in trial NCT04414397?
The interventions under investigation include: JUVÉDERM® VOLUMA® XC (DEVICE), No-treatment control (OTHER).
Who is sponsoring clinical trial NCT04414397?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.